← Scoopfeeds — Intelligent news, curated.
Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
business

Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

Bloomberg Markets · May 8, 2026, 8:37 AM · Also reported by 1 other source

Novo Nordisk A/S saw a 40% surge in sales of its diabetes and weight-loss drugs in India last month, after steep price cuts boosted demand for its branded treatments even as generic GLP-1 therapies flood the market.

Read full story on Bloomberg Markets → More top stories

Also covered by

Investing.com Evercore ISI raises BridgeBio Pharma price target on Attruby sales

More in business

Investing.com
Needham raises Nlight stock price target to $80 on strong Q1 beat
Investing.com
Needham raises Unity Software stock price target on Vector growth
Investing.com
Rosenblatt raises Datadog stock price target to $220 on strong Q1
Investing.com
Rosenblatt raises PDF Solutions stock price target on Q1 beat
Investing.com
Aletheia Capital initiates Circle Internet stock with buy rating
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop